Home

Orgenesis Inc. - Common Stock (ORGS)

2.1100
0.00 (0.00%)

Orgenesis Inc is a biotechnology company that specializes in the development and commercialization of cell and gene therapies

The company focuses on innovative treatment solutions aimed at addressing various diseases, including diabetes and liver disorders. Orgenesis is particularly known for its proprietary platform that enables the transformation of cells into therapeutically beneficial entities, potentially leading to groundbreaking advancements in regenerative medicine. Additionally, the company is involved in creating a global network of cell therapy facilities to streamline and optimize the manufacturing process, ensuring that advanced therapies are accessible to patients in need.

SummaryNewsPress ReleasesChartHistoricalFAQ
Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, Strengthening its Regenerative Medicine Portfolio with Spinal Cord Injury Therapies
Strategic Acquisition Designed to Expand Access to Cost-Effective, Scalable Regenerative Medicine Treatments
Via ACCESS Newswire · March 6, 2025
Orgenesis Secures Up to $5 Million Equity Investment from Williamsburg Venture Holdings
Funding Aimed at Accelerating Rollout of Decentralized CGT Platform
Via ACCESS Newswire · January 28, 2025
Cell and Gene Therapies Designed for Affordable and Accessible Point of Care Use, Deploying in California: Orgenesis, Inc. (NASDAQ: ORGS)
Orgenesis, Inc. (NASDAQ: ORGS ) is a global biotech company working to unlock the full potential of cell and gene therapies (CGTs) in an affordable and accessible format at the point of care. The ORGS POCare Platform is comprised of three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network.
Via Get News · April 5, 2023
Orgenesis to Present at the SNN Network Summer Virtual Event on Thursday, August 19, 2021
GERMANTOWN, MD / ACCESSWIRE / August 12, 2021 / Orgenesis Inc. (NASDAQ:ORGS), a global biotech company working to unlock the full potential of cell and gene therapies, today announced that it will be presenting at the SNN Network Summer Virtual Event 2021 on Thursday, August 19 at 8:00 am ET. Vered Caplan, CEO of Orgenesis, will be hosting the presentation and answering questions from investors. To access the live presentation, please use the
By Orgenesis Inc. · Via AccessWire · August 12, 2021
35 of the Best Ideas Companies to Present at the Summer Solstice - Best Ideas from the Buy-Side Virtual Investor Conference on June 1-4, 2021
RALEIGH, NC / ACCESSWIRE / May 27, 2021 / The Summer Solstice - Best Ideas from the Buy-Side will take place on June 1-4, 2021, where 35 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience. The Summer Solstice - Best Ideas from the Buy Side: VIRTUAL begins on Tuesday, June 1, 2021, with company presentations beginning at 9am Eastern Time. Presentations will be webcast on
By MicroCap Rodeo · Via AccessWire · May 27, 2021
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021
LOS ANGELES, CA / ACCESSWIRE / August 16, 2021 / The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be presenting via virtual webcast to a global investor audience. The SNN Network Summer Virtual Event begins on Tuesday, August 17, 2021 with the "MicroCap Investing Workshop" starting at 8:00am EST and featuring well-known financial influencers,
By Stock News Now · Via AccessWire · August 16, 2021